The Business Times
business-time-50

stem cell

Consumer & Healthcare

‘A GPS for stem cells’: TargaZyme’s Singapore CEO wants to cure cancer

Yakin Medic’s plans come on the heels of several measures unveiled by the Monetary Authority of Singapore’s review group to revive the local bourse.
Companies & Markets

Malaysian stem cell therapy provider Yakin Medic aims to raise RM100 million in Catalist IPO: report

Cordlife’s report to SGX RegCo noted more than 10 episodes between November 2020 and July 2022 when certain tanks had out-of-range temperature fluctuations.
Consumer & Healthcare

Cordlife probe finds temperature in one tank went as high as 20.4 deg C in 2021

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More